ArticleCancer science2021

Real-world safety of nivolumab in patients with non-small-cell lung cancer in Japan: Postmarketing surveillance.

Nobuyuki Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.